Crystal structure analysis of ethyl 6-(4-meth­oxy­phen­yl)-1-methyl-4-methyl­sulfanyl-3-phenyl-1H-pyrazolo­[3,4-b]pyridine-5-carboxyl­ate

H Surya Prakash Rao; Ramalingam Gunasundari; Jayaraman Muthukumaran

doi:10.1107/S2056989020008841

. 2020 Jul 7;76(Pt 8):1209–1212. doi: 10.1107/S2056989020008841

Crystal structure analysis of ethyl 6-(4-methoxyphenyl)-1-methyl-4-methylsulfanyl-3-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate

H Surya Prakash Rao ^a,^b,^*, Ramalingam Gunasundari ^b, Jayaraman Muthukumaran ^c,^‡

PMCID: PMC7405588 PMID: 32844001

In the title compound, the dihedral angle between the fused pyrazole and pyridine rings is 1.76 (7)°. The benzene and methoxy phenyl rings make dihedral angles of 44.8 (5) and 63.86 (5)°, respectively, with the pyrazolo[3,4-b] pyridine moiety. An intramolecular short S⋯O contact [3.215 (2) Å] is observed. The crystal packing features C—H⋯π interactions.

Keywords: crystal structure; pyrazolopyridine; pyrazolo[3,4-b]pyridine; C—H⋯π interactions

Abstract

In the title compound, C₂₄H₂₃N₃O₃S, the dihedral angle between the fused pyrazole and pyridine rings is 1.76 (7)°. The benzene and methoxy phenyl rings make dihedral angles of 44.8 (5) and 63.86 (5)°, respectively, with the pyrazolo[3,4-b] pyridine moiety. An intramolecular short S⋯O contact [3.215 (2) Å] is observed. The crystal packing features C—H⋯π interactions.

Chemical context

Pyrazolopyridines, in which a group of three nitrogen atoms is incorporated into a bicyclic heterocycle, are privileged medicinal scaffolds, often utilized in drug design and discovery regimes (Kumar et al., 2019 ▸). Owing to the possibilities of the easy synthesis of a literally unlimited number of a combinatorial library of small organic molecules with a pyrazolopyridine scaffold, there has been enormous interest in these molecules among medicinal chemists (Kumar et al. 2019 ▸; Pinheiro et al. 2019 ▸; Hardy, 1984 ▸). Indeed, molecules with pyrazolopyridine in the core structure exhibit multifaceted medicinal properties such as anti-microbial, anti-viral, anti-fungal, anti-hypertensive, analgesic, antiquorum-sensing, anti-cancer, anti-inflammatory, anti-Alzheimer’s, anti-diabetic, anti-nociceptive, anti-tuberculosis and anti-leishmanial activities (Hardy, 1984 ▸; Hawas et al., 2019 ▸; de Mello et al., 2004 ▸; El-Gohary et al., 2019 ▸; El-Gohary & Shaaban, 2018 ▸). Moreover, pyrazolopyridine-derived drug molecules exhibit anti-cancer properties (Huang et al., 2007 ▸; Ye et al., 2009 ▸). They are inhibitors of several important proteins, namely cycline-dependent kinase1, HIV reverse transcriptase, leucine zipper kinase, protein kinase, xanthine oxidase, interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), phosphodiesterase-4, NAD(P)H oxidases (Kumar et al., 2019 ▸; Gökhan-Kelekçi et al., 2007 ▸; Fathy et al., 2015 ▸; Park et al., 2017 ▸). A recent study reported that they could be promising inhibitors against the enzyme pantothenate synthetase from Mycobacterium tuberculosis (Amaroju et al., 2017 ▸). FDA-approved drugs incorporating the pyrazolopyridine scaffold include cartazolate, tracazolate and etazolate (Hawas et al., 2019 ▸). Among pyrazolopyridines, pyrazolo[3,4-b]pyridines are medicinally important because of the ease of combinatorial library synthesis, adherence to the Lipinski rule and favourable ADMET properties. (Chauhan & Kumar, 2013 ▸; Zhai et al., 2019 ▸). Based on the importance of pyrazolo[3,4-b]pyridine-containing molecules, we have undertaken a single-crystal X-ray diffraction study of the title compound. We have recently analyzed the solid-state structure of a pyrazolo[3,4-b]pyridine-containing molecule, ethyl 3-(4-chlorophenyl)-1,6-dimethyl-4-methylsulfanyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (NUDWOB; Rao et al. 2020 ▸), but the title compound exhibits a very different conformational structure of the substituents and supramolecular structure, as discussed here.

Structural commentary

In the title compound (Fig. 1 ▸), the phenyl (–C₆H₅) group attached to the pyrazolopyridine moiety exhibits a (+)anti-periplanar conformation [C12—C4—N1—N2 = 178.47 (14)°] whereas the methoxyphenyl (H₃COC₆H₄–) group exhibits a (−)anti-clinal conformation [C3—C5—C18—C23 = −114.30 (19)°]. The thiomethyl (–SCH₃) group fused to the pyrazolopyridine unit exhibits a (+)anti-periplanar conformation [C8—S1—C7—C6 = 175.47 (15)°]. The torsion angles involving the –SCH₃ group differ from those for NUDWOB (Rao et al. 2020 ▸) because of the presence of the methoxyphenyl (H₃COC₆H₄–) group. The –COOC₂H₅ group attached to the pyrazolopyridine moiety has a (+)anti-periplanar conformation [N3—C7—C6—C9 = 176.44 (16)°]. Further, the methyl group attached to the pyrazole subunit is (+)anti-periplanar [C1—N2—N1—C4 = 178.78 (17)°] and it is attached to the pyridine ring showing a (+)syn-periplanar conformation [C1—N2—C2—N3 = 1.3 (3)°]. The fused pyrazole and pyridine rings in the title compound are not exactly planar, as in NUDWOB (Rao et al. 2020 ▸), subtending a dihedral angle of 1.76 (7)°. The dihedral angle between the planes of the benzene and pyrazolo[3,4-b]pyridine rings is 44.8 (5)° and that between the methoxyphenyl and pyrazolo[3,4-b]pyridine rings is 63.86 (5)°.

The molecular structure of the title compound with the atom-numbering scheme and displacement ellipsoids drawn at the 50% probability level. The short intramolecular S⋯O interaction is indicated by a dashed line.

Supramolecular features

The cohesion of the crystal packing is influenced by two weak C—H⋯π (C13—H13⋯Cg and C23—H23⋯Cg) interactions (Table 1 ▸, Fig. 2 ▸) with distances of 2.86 and 3.02 Å, respectively. These distances agree with those described by Nishio (2011 ▸). A short intermolecular C⋯O carbon=bonding stabilizing interaction [C1⋯O1(x + 1, y, z) = 3.291 (2) Å] may also exist (Fig. 2 ▸) between the electrophilic carbon atom of the methyl group connected to the electronegative nitrogen atom of the pyrazolo ring and the nucleophilic oxygen atom of the ester group of a neighbouring molecule. However, the distance between C1 and O1 is marginally higher than the carbon-bonding distances (less than 3.22 Å, the sum of the van der Waals radii of carbon and oxygen atoms) proposed by Guru Row and co-workers (Thomas et al., 2014 ▸). The distances between the methyl hydrogen atoms and the acceptor oxygen atom are C—H1A⋯O1 = 3.06, C—H1B⋯O1 = 3.04 and C—H1C⋯O1 = 3.22 Å, much longer than the hydrogen-bonding interactions (C—H⋯O = 2.90, 2.84 and 2.86 Å) noted by Thomas et al. (2014 ▸). Based on these observations, in addition to the C—H⋯π interactions, the short intermolecular C⋯O carbon-bonding interaction may also contribute to the cohesion of the title compound in the solid state.

Table 1. Hydrogen-bond geometry (Å, °).

Cg1 and Cg2 are the centroids of the N1/N2/C2–C4 and the N3/C2/C3/C5–C7 rings, respectively.

D—H⋯A	D—H	H⋯A	D⋯A	D—H⋯A
C13—H13⋯Cg1ⁱ	0.93	2.85	3.455 (2)	124
C23—H23⋯Cg2ⁱⁱ	0.93	3.02	3.738 (2)	136

Open in a new tab

Symmetry codes: (i) Inline graphic ; (ii) .

A view of the weak intermolecular C13—H13⋯Cg(N1/N2/C2–C4), C23—H13⋯Cg(N3/C2/C3/C5–C7) and C1⋯O1 interactions in the title compound.

Database survey

A similarity search of the Cambridge Structural Database (CSD, Version 5.40, update of March 2020; Groom et al., 2016 ▸) was performed. The title compound, along with related structures obtained from the database search could be used for further structure-based virtual screening, ligand-based virtual screening, pharmacophore-based virtual screening and drug repurposing against various drug target proteins. The molecules showing strong binding affinity towards drug target proteins might be considered potential lead candidates. In this study, the CSD search found five molecules that are similar to title compound, namely FIZLEI (ethyl 2,7-diamino-3,4-dicyano-5-phenylpyrazolo[1,5-a]pyridine-6-carboxylate; Naik et al., 2019 ▸), ALAFID [7-(2-methoxyphenyl)-2-phenylpyrazolo[1,5-a]pyridine; Wu et al., 2016 ▸], DAWKAQ [2-(4-chlorophenyl)pyrazolo[1,5-a]pyridin-3-yl(phenyl)methanone; Ravi et al., 2017 ▸], NADPIU [3-(4-chlorophenyl)pyrazolo[1,5-a]pyridine; Wu et al., 2016 ▸] and NUDWOB [ethyl 3-(4-chlorophenyl)-1,6-dimethyl-4-(methylsulfanyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate; Rao et al., 2020 ▸]. The geometrical parameters of the –COOCH₂CH₃ substituent in the title compound are comparable with those reported for FIZLEI and NUDWOB. The bond distances for the thiomethyl and aryl moieties in the title compound are comparable with those of NUDWOB. Moreover, the bond lengths in the pyrazolo[3,4-b]pyridine unit of the title compound are comparable with those in NUDWOB, FIZLEI, ALAFID, DAWKAQ and NADPIU. The pyrazolo[3,4-b]pyridine moiety (N1–N3/C2–C4/C5–C7) of the title compound is approximately planar, as is also observed for NUDWOB, FIZLEI, ALAFID, DAWKAQ and NADPIU. In the title compound, a short intramolecular S⋯O contact of 3.215 (2) Å occurs, but this is not observed in FIZLEI, ALAFID, DAWKAQ, NADPIU and NUDWOB. Moreover, the interaction distance [3.291 (2) Å] of the short intermolecular C⋯O contact in the title compound is comparable with the C⋯O interaction [3.424 (2) Å] in the structure of NUDWOB. Furthermore, as in the title compound, C—H⋯π interactions are observed in the crystal structures of ALAFID, DAWKAQ and NADPIU. The interaction distance of these related structures ranges from 2.89 to 3.23 Å, comparable with the C—H⋯π interactions observed in the title compound.

Synthesis and crystallization

To a solution of 1-methyl-3-phenyl-1H-pyrazol-5-amine (100 mg, 0.57 mmol) and ethyl 2-(4-methoxybenzoyl)-3,3-bis(methylthio)acrylate (188 mg, 0.57 mmol) in toluene (3 mL), a catalytic amount of TFA (trifluoroacetic acid) 30 mol % in toluene (3 mL) was added under an N₂ atmosphere. The reaction mixture was refluxed for 24 h in an oil bath, the progress of the reaction being monitored by TLC using a mixture of hexane and ethyl acetate (9.9:0.1). After completion of the reaction, the mixture was loaded on a silica gel column (100–200 mesh, 15 cm × 1 cm) and eluted with increasing amounts of ethyl acetate in hexanes (1% to 5%) to obtain 186 mg (yield = 75%) of ethyl 6-(4-methoxyphenyl)-1-methyl-4-(methylthio)-3-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate as a colourless crystalline solid; m.p. 406 K; R _f = 0.3 cm (hexane: ethyl acetate 9.9:0.1). A sample suitable for single-crystal X-ray analysis was obtained by recrystallization from 2 mL of dry methanol.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The hydrogen atoms were placed in calculated positions, with C—H = 0.93–0.97 Å and included in the final cycles of refinement using a riding model with U _iso(H) = 1.2U _eq(C) or 1.5U _eq(C-methyl).

Table 2. Experimental details.

Crystal data
Chemical formula	C₂₄H₂₃N₃O₃S
M _r	433.51
Crystal system, space group	Triclinic, P
Temperature (K)	298
a, b, c (Å)	10.1911 (4), 10.7274 (6), 11.7692 (6)
α, β, γ (°)	98.550 (5), 105.632 (4), 111.015 (4)
V (Å³)	1112.75 (10)
Z	2
Radiation type	Mo Kα
μ (mm⁻¹)	0.18
Crystal size (mm)	0.75 × 0.44 × 0.42

Data collection
Diffractometer	Agilent Xcalibur, Eos
Absorption correction	Multi-scan (CrysAlis PRO; Agilent, 2014 ▸)
T _min, T _max	0.959, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections	13297, 5161, 3672
R _int	0.026
(sin θ/λ)_max (Å⁻¹)	0.686

Refinement
R[F ² > 2σ(F ²)], wR(F ²), S	0.048, 0.168, 1.06
No. of reflections	5161
No. of parameters	284
H-atom treatment	H-atom parameters constrained
Δρ_max, Δρ_min (e Å⁻³)	0.20, −0.26

Open in a new tab

Computer programs: CrysAlis PRO (Agilent, 2014 ▸), SHELXT (Sheldrick, 2015 ▸), SHELXL2018 (Sheldrick, 2015 ▸), ORTEP-3 for Windows (Farrugia, 2012 ▸), PLATON (Spek, 2020 ▸) and Mercury (Macrae et al., 2020 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989020008841/dx2029sup1.cif

e-76-01209-sup1.cif^{(459.8KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989020008841/dx2029Isup2.hkl

e-76-01209-Isup2.hkl^{(410.6KB, hkl)}

Click here for additional data file.^{(8.4KB, cml)}

Supporting information file. DOI: 10.1107/S2056989020008841/dx2029Isup3.cml

CCDC reference: 2005976

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

HSPRao thanks DST–FIST Single Crystal XRD facility at Department of Chemistry, Pondicherry University for the diffraction data. RG thanks the Department of Chemistry for facilities, and the UGC and CSIR for a fellowship. JM thanks Dr Clara Gomes (FCT–UNL, Portugal) for the CSD database survey and Dr Amit Kumar Singh (Sharda University, India) for support.

supplementary crystallographic information

Crystal data

C₂₄H₂₃N₃O₃S	Z = 2
M_r = 433.51	F(000) = 456
Triclinic, P1	D_x = 1.294 Mg m⁻³
a = 10.1911 (4) Å	Mo Kα radiation, λ = 0.71073 Å
b = 10.7274 (6) Å	Cell parameters from 3586 reflections
c = 11.7692 (6) Å	θ = 3.8–29.1°
α = 98.550 (5)°	µ = 0.18 mm⁻¹
β = 105.632 (4)°	T = 298 K
γ = 111.015 (4)°	Block, colorless
V = 1112.75 (10) Å³	0.75 × 0.44 × 0.42 mm

Open in a new tab

Data collection

Agilent Xcalibur, Eos diffractometer	5161 independent reflections
Radiation source: Enhance (Mo) X-ray Source	3672 reflections with I > 2σ(I)
Detector resolution: 15.9821 pixels mm^-1	R_int = 0.026
ω scans	θ_max = 29.2°, θ_min = 3.8°
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2014)	h = −13→12
T_min = 0.959, T_max = 1.000	k = −13→14
13297 measured reflections	l = −15→15

Open in a new tab

Refinement

Refinement on F²	Primary atom site location: structure-invariant direct methods
Least-squares matrix: full	Secondary atom site location: difference Fourier map
R[F² > 2σ(F²)] = 0.048	Hydrogen site location: inferred from neighbouring sites
wR(F²) = 0.168	H-atom parameters constrained
S = 1.06	w = 1/[σ²(F_o²) + (0.1P)²] where P = (F_o² + 2F_c²)/3
5161 reflections	(Δ/σ)_max < 0.001
284 parameters	Δρ_max = 0.20 e Å⁻³
0 restraints	Δρ_min = −0.26 e Å⁻³

Open in a new tab

Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Open in a new tab

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

	x	y	z	U_iso*/U_eq
S1	0.67085 (6)	0.56012 (6)	0.41095 (5)	0.0647 (2)
O2	0.38290 (15)	0.56954 (14)	0.22189 (15)	0.0618 (4)
N3	0.72006 (14)	0.40967 (14)	0.23884 (14)	0.0456 (4)
O3	−0.16778 (14)	0.10375 (17)	−0.27340 (14)	0.0716 (4)
O1	0.26375 (16)	0.36781 (15)	0.25921 (15)	0.0716 (4)
N2	0.74888 (15)	0.26571 (16)	0.08007 (15)	0.0507 (4)
N1	0.66463 (15)	0.17775 (16)	−0.03455 (15)	0.0524 (4)
C6	0.46748 (17)	0.39796 (17)	0.18528 (16)	0.0426 (4)
C18	0.25937 (17)	0.25136 (17)	−0.01408 (15)	0.0403 (4)
C5	0.41691 (17)	0.30623 (16)	0.07038 (15)	0.0397 (4)
C23	0.2031 (2)	0.33918 (19)	−0.06467 (18)	0.0509 (4)
H23	0.262169	0.434277	−0.040467	0.061*
C19	0.16737 (17)	0.11066 (18)	−0.05037 (16)	0.0450 (4)
H19	0.203616	0.050794	−0.017572	0.054*
C4	0.52914 (18)	0.17844 (18)	−0.06206 (17)	0.0440 (4)
C3	0.52331 (17)	0.26645 (16)	0.03830 (16)	0.0403 (4)
C12	0.41458 (18)	0.09398 (18)	−0.18366 (16)	0.0443 (4)
C21	−0.02998 (18)	0.1451 (2)	−0.18636 (17)	0.0507 (4)
C20	0.02258 (18)	0.05683 (19)	−0.13439 (16)	0.0491 (4)
H20	−0.038626	−0.037581	−0.155630	0.059*
C7	0.61907 (18)	0.44751 (18)	0.26597 (17)	0.0451 (4)
C17	0.3250 (2)	0.1467 (2)	−0.25396 (17)	0.0518 (4)
H17	0.335347	0.236158	−0.223765	0.062*
C22	0.0606 (2)	0.2860 (2)	−0.15032 (19)	0.0575 (5)
H22	0.024819	0.345484	−0.184333	0.069*
C1	0.9027 (2)	0.2863 (3)	0.1384 (2)	0.0737 (6)
H1A	0.954270	0.370449	0.204079	0.110*
H1B	0.952102	0.292919	0.079218	0.110*
H1C	0.903503	0.209297	0.170462	0.110*
C2	0.66831 (17)	0.32140 (18)	0.12734 (17)	0.0435 (4)
C16	0.2213 (2)	0.0669 (2)	−0.36804 (19)	0.0632 (5)
H16	0.161631	0.102596	−0.414423	0.076*
C13	0.3980 (2)	−0.0386 (2)	−0.23167 (19)	0.0583 (5)
H13	0.458611	−0.074552	−0.186802	0.070*
C9	0.35959 (19)	0.44074 (19)	0.22766 (17)	0.0477 (4)
C10	0.2937 (3)	0.6327 (2)	0.2651 (3)	0.0740 (7)
H10A	0.202428	0.560492	0.264182	0.089*
H10B	0.265806	0.685559	0.210502	0.089*
C15	0.2054 (3)	−0.0656 (2)	−0.4137 (2)	0.0716 (6)
H15	0.135537	−0.119091	−0.490858	0.086*
C8	0.8584 (2)	0.5829 (3)	0.4825 (2)	0.0821 (7)
H8A	0.859059	0.495191	0.489817	0.123*
H8B	0.900377	0.646868	0.562541	0.123*
H8C	0.917043	0.619009	0.433710	0.123*
C11	0.3801 (3)	0.7253 (3)	0.3911 (3)	0.0868 (8)
H11A	0.402829	0.671847	0.445827	0.130*
H11B	0.321725	0.769022	0.416900	0.130*
H11C	0.471812	0.795051	0.392304	0.130*
C24	−0.2684 (2)	−0.0390 (3)	−0.3089 (3)	0.0881 (8)
H24A	−0.228284	−0.093559	−0.348676	0.132*
H24B	−0.363754	−0.052474	−0.364364	0.132*
H24C	−0.280979	−0.067455	−0.237465	0.132*
C14	0.2926 (3)	−0.1182 (2)	−0.3453 (2)	0.0756 (7)
H14	0.280866	−0.208232	−0.375564	0.091*

Open in a new tab

Atomic displacement parameters (Å²)

	U¹¹	U²²	U³³	U¹²	U¹³	U²³
S1	0.0602 (3)	0.0687 (4)	0.0507 (3)	0.0333 (3)	−0.0005 (2)	−0.0037 (3)
O2	0.0566 (7)	0.0531 (8)	0.0840 (11)	0.0294 (6)	0.0309 (7)	0.0137 (7)
N3	0.0379 (7)	0.0429 (8)	0.0482 (9)	0.0157 (6)	0.0063 (6)	0.0105 (7)
O3	0.0436 (7)	0.0890 (11)	0.0611 (10)	0.0256 (7)	−0.0054 (7)	0.0109 (8)
O1	0.0659 (9)	0.0703 (10)	0.0955 (12)	0.0307 (7)	0.0459 (9)	0.0313 (9)
N2	0.0348 (7)	0.0594 (9)	0.0538 (10)	0.0211 (6)	0.0110 (7)	0.0093 (8)
N1	0.0436 (8)	0.0610 (10)	0.0527 (10)	0.0239 (7)	0.0166 (7)	0.0112 (8)
C6	0.0380 (8)	0.0409 (9)	0.0459 (10)	0.0173 (7)	0.0096 (7)	0.0109 (8)
C18	0.0347 (8)	0.0456 (9)	0.0397 (9)	0.0177 (7)	0.0101 (7)	0.0123 (7)
C5	0.0366 (8)	0.0395 (8)	0.0419 (9)	0.0163 (6)	0.0099 (7)	0.0144 (7)
C23	0.0478 (9)	0.0459 (10)	0.0541 (11)	0.0218 (8)	0.0078 (8)	0.0129 (8)
C19	0.0405 (9)	0.0471 (9)	0.0474 (10)	0.0181 (7)	0.0137 (8)	0.0167 (8)
C4	0.0400 (8)	0.0466 (9)	0.0459 (10)	0.0178 (7)	0.0155 (7)	0.0141 (8)
C3	0.0359 (8)	0.0391 (8)	0.0440 (10)	0.0155 (6)	0.0101 (7)	0.0137 (7)
C12	0.0414 (8)	0.0489 (10)	0.0404 (10)	0.0150 (7)	0.0174 (7)	0.0098 (8)
C21	0.0370 (9)	0.0682 (12)	0.0419 (10)	0.0220 (8)	0.0081 (8)	0.0120 (9)
C20	0.0388 (9)	0.0520 (10)	0.0486 (11)	0.0124 (7)	0.0131 (8)	0.0130 (8)
C7	0.0411 (8)	0.0406 (9)	0.0452 (10)	0.0154 (7)	0.0059 (7)	0.0097 (7)
C17	0.0512 (10)	0.0547 (11)	0.0459 (11)	0.0210 (8)	0.0145 (8)	0.0111 (9)
C22	0.0532 (10)	0.0623 (12)	0.0574 (12)	0.0329 (9)	0.0073 (9)	0.0182 (10)
C1	0.0404 (10)	0.0916 (16)	0.0792 (16)	0.0328 (10)	0.0088 (10)	0.0052 (13)
C2	0.0370 (8)	0.0442 (9)	0.0484 (10)	0.0180 (7)	0.0112 (7)	0.0149 (8)
C16	0.0566 (11)	0.0755 (14)	0.0472 (12)	0.0219 (10)	0.0108 (9)	0.0167 (11)
C13	0.0737 (12)	0.0529 (11)	0.0523 (12)	0.0292 (9)	0.0241 (10)	0.0152 (9)
C9	0.0413 (9)	0.0508 (10)	0.0460 (10)	0.0199 (7)	0.0098 (8)	0.0077 (8)
C10	0.0638 (13)	0.0697 (14)	0.1010 (19)	0.0400 (11)	0.0353 (13)	0.0147 (13)
C15	0.0773 (14)	0.0637 (14)	0.0447 (12)	0.0073 (11)	0.0135 (11)	0.0049 (10)
C8	0.0566 (12)	0.0955 (18)	0.0603 (15)	0.0251 (12)	−0.0075 (11)	−0.0043 (13)
C11	0.1061 (19)	0.0984 (19)	0.0812 (19)	0.0613 (16)	0.0479 (16)	0.0204 (16)
C24	0.0442 (11)	0.1039 (19)	0.0718 (17)	0.0056 (11)	−0.0057 (11)	0.0133 (15)
C14	0.1098 (18)	0.0521 (12)	0.0520 (13)	0.0261 (12)	0.0237 (13)	0.0066 (10)

Open in a new tab

Geometric parameters (Å, º)

S1—C7	1.7590 (19)	C12—C17	1.392 (3)
S1—C8	1.777 (2)	C21—C22	1.383 (3)
O2—C9	1.331 (2)	C21—C20	1.385 (3)
O2—C10	1.460 (2)	C20—H20	0.9300
N3—C7	1.328 (2)	C17—C16	1.378 (3)
N3—C2	1.340 (2)	C17—H17	0.9300
O3—C21	1.364 (2)	C22—H22	0.9300
O3—C24	1.423 (3)	C1—H1A	0.9600
O1—O1	0.000 (4)	C1—H1B	0.9600
O1—C9	1.199 (2)	C1—H1C	0.9600
N2—C2	1.356 (2)	C16—C15	1.377 (3)
N2—N1	1.365 (2)	C16—H16	0.9300
N2—C1	1.450 (2)	C13—C14	1.378 (3)
N1—C4	1.334 (2)	C13—H13	0.9300
C6—C5	1.388 (2)	C10—C11	1.481 (3)
C6—C7	1.429 (2)	C10—H10A	0.9700
C6—C9	1.503 (2)	C10—H10B	0.9700
C18—C19	1.385 (2)	C15—C14	1.366 (4)
C18—C23	1.393 (2)	C15—H15	0.9300
C18—C5	1.483 (2)	C8—H8A	0.9600
C5—C3	1.416 (2)	C8—H8B	0.9600
C23—C22	1.377 (3)	C8—H8C	0.9600
C23—H23	0.9300	C11—H11A	0.9600
C19—C20	1.386 (2)	C11—H11B	0.9600
C19—H19	0.9300	C11—H11C	0.9600
C4—C3	1.427 (2)	C24—H24A	0.9600
C4—C12	1.479 (2)	C24—H24B	0.9600
C3—C2	1.409 (2)	C24—H24C	0.9600
C12—C13	1.381 (3)	C14—H14	0.9300

C7—S1—C8	102.08 (11)	H1A—C1—H1B	109.5
C9—O2—C10	118.64 (16)	N2—C1—H1C	109.5
C7—N3—C2	114.13 (14)	H1A—C1—H1C	109.5
C21—O3—C24	117.99 (17)	H1B—C1—H1C	109.5
C2—N2—N1	111.38 (13)	N3—C2—N2	125.09 (15)
C2—N2—C1	127.81 (17)	N3—C2—C3	128.10 (15)
N1—N2—C1	120.77 (16)	N2—C2—C3	106.80 (15)
C4—N1—N2	106.91 (14)	C15—C16—C17	120.3 (2)
C5—C6—C7	120.93 (15)	C15—C16—H16	119.9
C5—C6—C9	119.54 (14)	C17—C16—H16	119.9
C7—C6—C9	119.47 (16)	C14—C13—C12	120.77 (19)
C19—C18—C23	118.28 (15)	C14—C13—H13	119.6
C19—C18—C5	120.91 (14)	C12—C13—H13	119.6
C23—C18—C5	120.70 (15)	O1—C9—O2	124.91 (16)
C6—C5—C3	116.49 (14)	O1—C9—O2	124.91 (16)
C6—C5—C18	121.92 (14)	O1—C9—C6	124.73 (17)
C3—C5—C18	121.59 (15)	O1—C9—C6	124.73 (17)
C22—C23—C18	120.38 (17)	O2—C9—C6	110.33 (15)
C22—C23—H23	119.8	O2—C10—C11	110.43 (19)
C18—C23—H23	119.8	O2—C10—H10A	109.6
C18—C19—C20	121.62 (15)	C11—C10—H10A	109.6
C18—C19—H19	119.2	O2—C10—H10B	109.6
C20—C19—H19	119.2	C11—C10—H10B	109.6
N1—C4—C3	110.06 (15)	H10A—C10—H10B	108.1
N1—C4—C12	118.69 (16)	C14—C15—C16	119.8 (2)
C3—C4—C12	131.25 (14)	C14—C15—H15	120.1
C2—C3—C5	116.67 (15)	C16—C15—H15	120.1
C2—C3—C4	104.82 (14)	S1—C8—H8A	109.5
C5—C3—C4	138.47 (15)	S1—C8—H8B	109.5
C13—C12—C17	118.49 (17)	H8A—C8—H8B	109.5
C13—C12—C4	120.04 (16)	S1—C8—H8C	109.5
C17—C12—C4	121.44 (16)	H8A—C8—H8C	109.5
O3—C21—C22	115.77 (17)	H8B—C8—H8C	109.5
O3—C21—C20	124.66 (17)	C10—C11—H11A	109.5
C22—C21—C20	119.56 (16)	C10—C11—H11B	109.5
C21—C20—C19	119.30 (17)	H11A—C11—H11B	109.5
C21—C20—H20	120.4	C10—C11—H11C	109.5
C19—C20—H20	120.4	H11A—C11—H11C	109.5
N3—C7—C6	123.66 (17)	H11B—C11—H11C	109.5
N3—C7—S1	118.89 (13)	O3—C24—H24A	109.5
C6—C7—S1	117.42 (13)	O3—C24—H24B	109.5
C16—C17—C12	120.30 (19)	H24A—C24—H24B	109.5
C16—C17—H17	119.9	O3—C24—H24C	109.5
C12—C17—H17	119.9	H24A—C24—H24C	109.5
C23—C22—C21	120.80 (17)	H24B—C24—H24C	109.5
C23—C22—H22	119.6	C15—C14—C13	120.3 (2)
C21—C22—H22	119.6	C15—C14—H14	119.8
N2—C1—H1A	109.5	C13—C14—H14	119.8
N2—C1—H1B	109.5

C2—N2—N1—C4	0.92 (19)	C5—C6—C7—S1	−178.50 (13)
C1—N2—N1—C4	178.78 (17)	C9—C6—C7—S1	−1.3 (2)
C7—C6—C5—C3	−0.5 (2)	C8—S1—C7—N3	−2.36 (18)
C9—C6—C5—C3	−177.72 (15)	C8—S1—C7—C6	175.47 (15)
C7—C6—C5—C18	178.87 (14)	C13—C12—C17—C16	0.8 (3)
C9—C6—C5—C18	1.6 (2)	C4—C12—C17—C16	178.66 (16)
C19—C18—C5—C6	−117.54 (18)	C18—C23—C22—C21	0.9 (3)
C23—C18—C5—C6	66.4 (2)	O3—C21—C22—C23	−178.79 (18)
C19—C18—C5—C3	61.8 (2)	C20—C21—C22—C23	0.9 (3)
C23—C18—C5—C3	−114.30 (19)	C7—N3—C2—N2	−178.44 (16)
C19—C18—C23—C22	−1.3 (3)	C7—N3—C2—C3	0.3 (2)
C5—C18—C23—C22	174.93 (17)	N1—N2—C2—N3	178.93 (15)
C23—C18—C19—C20	−0.2 (3)	C1—N2—C2—N3	1.3 (3)
C5—C18—C19—C20	−176.43 (16)	N1—N2—C2—C3	0.00 (19)
N2—N1—C4—C3	−1.47 (18)	C1—N2—C2—C3	−177.67 (18)
N2—N1—C4—C12	178.47 (14)	C5—C3—C2—N3	−1.5 (3)
C6—C5—C3—C2	1.5 (2)	C4—C3—C2—N3	−179.75 (16)
C18—C5—C3—C2	−177.89 (14)	C5—C3—C2—N2	177.41 (14)
C6—C5—C3—C4	178.94 (18)	C4—C3—C2—N2	−0.86 (17)
C18—C5—C3—C4	−0.4 (3)	C12—C17—C16—C15	−0.2 (3)
N1—C4—C3—C2	1.46 (18)	C17—C12—C13—C14	−1.6 (3)
C12—C4—C3—C2	−178.47 (17)	C4—C12—C13—C14	−179.45 (18)
N1—C4—C3—C5	−176.19 (19)	O1—O1—C9—O2	0.00 (13)
C12—C4—C3—C5	3.9 (3)	O1—O1—C9—C6	0.00 (9)
N1—C4—C12—C13	42.4 (2)	C10—O2—C9—O1	4.7 (3)
C3—C4—C12—C13	−137.69 (19)	C10—O2—C9—O1	4.7 (3)
N1—C4—C12—C17	−135.43 (18)	C10—O2—C9—C6	−177.05 (17)
C3—C4—C12—C17	44.5 (3)	C5—C6—C9—O1	73.3 (2)
C24—O3—C21—C22	−176.7 (2)	C7—C6—C9—O1	−104.0 (2)
C24—O3—C21—C20	3.6 (3)	C5—C6—C9—O1	73.3 (2)
O3—C21—C20—C19	177.29 (17)	C7—C6—C9—O1	−104.0 (2)
C22—C21—C20—C19	−2.4 (3)	C5—C6—C9—O2	−104.97 (18)
C18—C19—C20—C21	2.1 (3)	C7—C6—C9—O2	77.8 (2)
C2—N3—C7—C6	0.9 (2)	C9—O2—C10—C11	99.1 (2)
C2—N3—C7—S1	178.58 (12)	C17—C16—C15—C14	0.3 (3)
C5—C6—C7—N3	−0.8 (3)	C16—C15—C14—C13	−1.0 (4)
C9—C6—C7—N3	176.44 (16)	C12—C13—C14—C15	1.7 (3)

Open in a new tab

Hydrogen-bond geometry (Å, º)

Cg1 and Cg2 are the centroids of the N1/N2/C2–C4 and the N3/C2/C3/C5–C7 rings, respectively.

D—H···A	D—H	H···A	D···A	D—H···A
C13—H13···Cg1ⁱ	0.93	2.85	3.455 (2)	124
C23—H23···Cg2ⁱⁱ	0.93	3.02	3.738 (2)	136

Open in a new tab

Symmetry codes: (i) −x+1, −y, −z; (ii) −x+1, −y+1, −z.

References

Agilent (2014). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.
Amaroju, S., Kalaga, M. N., Srinivasarao, S., Napiórkowska, A., Augustynowicz-Kopeć, E., Murugesan, S., Chander, S., Krishnan, R. & Chandra Sekhar, K. V. G. (2017). New J. Chem. 41, 347–357.
Chauhan, M. & Kumar, R. (2013). Bioorg. Med. Chem. 21, 5657–5668. [DOI] [PubMed]
El-Gohary, N. S., Gabr, M. T. & Shaaban, M. I. (2019). Bioorg. Chem. 89, 1–13. [DOI] [PubMed]
El-Gohary, N. S. & Shaaban, M. I. (2018). Eur. J. Med. Chem. 152, 126–136. [DOI] [PubMed]
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
Fathy, U., Younis, A. & Awad, H. M. (2015). J. Chem. Pharm. Res. 7, 4–12.
Gökhan-Kelekçi, N., Yabanoğlu, S., Küpeli, E., Salgin, U., Ozgen, O., Uçar, G., Yeşilada, E., Kendi, E., Yeşilada, A. & Bilgin, A. A. A. (2007). Bioorg. Med. Chem. 15, 5775–5786. [DOI] [PubMed]
Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
Hardy, C. R. (1984). In Advances in Heterocyclic Chemistry, Vol. 36, pp. 343–409. New York: Academic Press.
Hawas, S. S., El-Gohary, N. S., Gabr, M. T., Shaaban, M. I. & El-Ashmawy, M. B. (2019). Synth. Commun. 49, 2466–2487.
Huang, S., Lin, R., Yu, Y., Lu, Y., Connolly, P. J., Chiu, G., Li, S., Emanuel, S. L. & Middleton, S. A. (2007). Bioorg. Med. Chem. Lett. 17, 1243–1245. [DOI] [PubMed]
Kumar, S. V., Muthusubramanian, S. & Perumal, S. (2019). Org. Prep. Proced. Int. 51, 1–89.
Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst. 53, 226–235. [DOI] [PMC free article] [PubMed]
Mello, H. de, Echevarria, A., Bernardino, A. M., Canto-Cavalheiro, M. & Leon, L. L. (2004). J. Med. Chem. 47, 5427–5432. [DOI] [PubMed]
Naik, N. S., Shastri, L. A., Shastri, S. L., Chougala, B. M., Shaikh, F., Madar, J. M., Kulkarni, R. C., Dodamani, S., Jalalpure, S., Joshi, S. D. & Sunagar, V. (2019). Chemistry Select, 4, 285–297.
Nishio, M. (2011). Phys. Chem. Chem. Phys. 13, 13878–13900.
Park, C. M., Jadhav, V. B., Song, J. H., Lee, S., Won, H. Y., Choi, S. U. & Son, Y. H. (2017). Bull. Korean Chem. Soc. 38, 595–602.
Pinheiro, L. C. S., Feitosa, L. M., Gandi, M. O., Silveira, F. F. & Boechat, N. (2019). Molecules, 24, 4095.
Rao, H. S. P., Gunasundari, R. & Muthukumaran, J. (2020). Acta Cryst. E76, 443–445. [DOI] [PMC free article] [PubMed]
Ravi, C., Samanta, S., Mohan, D. C., Reddy, N. N. K. & Adimurthy, S. (2017). Synthesis, 49, 2513–2522.
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
Spek, A. L. (2020). Acta Cryst. E76, 1–11. [DOI] [PMC free article] [PubMed]
Thomas, S. P., Pavan, M. S. & Guru Row, T. N. (2014). Chem. Commun. 50, 49–51. [DOI] [PubMed]
Wu, H.-C., Chu, J.-H., Li, C.-W., Hwang, L.-C. & Wu, M.-J. (2016). Organometallics, 35, 288–300.
Ye, Q., Cao, J., Zhou, X., Lv, D., He, Q., Yang, B. & Hu, Y. (2009). Bioorg. Med. Chem. 17, 4763–4772. [DOI] [PubMed]
Zhai, M., Liu, S., Gao, M., Wang, L., Sun, J., Du, J., Guan, Q., Bao, K., Zuo, D., Wu, Y. & Zhang, W. (2019). Eur. J. Med. Chem. 168, 426–435. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989020008841/dx2029sup1.cif

e-76-01209-sup1.cif^{(459.8KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989020008841/dx2029Isup2.hkl

e-76-01209-Isup2.hkl^{(410.6KB, hkl)}

Click here for additional data file.^{(8.4KB, cml)}

Supporting information file. DOI: 10.1107/S2056989020008841/dx2029Isup3.cml

CCDC reference: 2005976

Additional supporting information: crystallographic information; 3D view; checkCIF report

[bb1] Agilent (2014). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.

[bb2] Amaroju, S., Kalaga, M. N., Srinivasarao, S., Napiórkowska, A., Augustynowicz-Kopeć, E., Murugesan, S., Chander, S., Krishnan, R. & Chandra Sekhar, K. V. G. (2017). New J. Chem. 41, 347–357.

[bb3] Chauhan, M. & Kumar, R. (2013). Bioorg. Med. Chem. 21, 5657–5668. [DOI] [PubMed]

[bb4] El-Gohary, N. S., Gabr, M. T. & Shaaban, M. I. (2019). Bioorg. Chem. 89, 1–13. [DOI] [PubMed]

[bb5] El-Gohary, N. S. & Shaaban, M. I. (2018). Eur. J. Med. Chem. 152, 126–136. [DOI] [PubMed]

[bb6] Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.

[bb7] Fathy, U., Younis, A. & Awad, H. M. (2015). J. Chem. Pharm. Res. 7, 4–12.

[bb8] Gökhan-Kelekçi, N., Yabanoğlu, S., Küpeli, E., Salgin, U., Ozgen, O., Uçar, G., Yeşilada, E., Kendi, E., Yeşilada, A. & Bilgin, A. A. A. (2007). Bioorg. Med. Chem. 15, 5775–5786. [DOI] [PubMed]

[bb9] Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]

[bb10] Hardy, C. R. (1984). In Advances in Heterocyclic Chemistry, Vol. 36, pp. 343–409. New York: Academic Press.

[bb11] Hawas, S. S., El-Gohary, N. S., Gabr, M. T., Shaaban, M. I. & El-Ashmawy, M. B. (2019). Synth. Commun. 49, 2466–2487.

[bb12] Huang, S., Lin, R., Yu, Y., Lu, Y., Connolly, P. J., Chiu, G., Li, S., Emanuel, S. L. & Middleton, S. A. (2007). Bioorg. Med. Chem. Lett. 17, 1243–1245. [DOI] [PubMed]

[bb13] Kumar, S. V., Muthusubramanian, S. & Perumal, S. (2019). Org. Prep. Proced. Int. 51, 1–89.

[bb14] Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst. 53, 226–235. [DOI] [PMC free article] [PubMed]

[bb15] Mello, H. de, Echevarria, A., Bernardino, A. M., Canto-Cavalheiro, M. & Leon, L. L. (2004). J. Med. Chem. 47, 5427–5432. [DOI] [PubMed]

[bb16] Naik, N. S., Shastri, L. A., Shastri, S. L., Chougala, B. M., Shaikh, F., Madar, J. M., Kulkarni, R. C., Dodamani, S., Jalalpure, S., Joshi, S. D. & Sunagar, V. (2019). Chemistry Select, 4, 285–297.

[bb17] Nishio, M. (2011). Phys. Chem. Chem. Phys. 13, 13878–13900.

[bb18] Park, C. M., Jadhav, V. B., Song, J. H., Lee, S., Won, H. Y., Choi, S. U. & Son, Y. H. (2017). Bull. Korean Chem. Soc. 38, 595–602.

[bb19] Pinheiro, L. C. S., Feitosa, L. M., Gandi, M. O., Silveira, F. F. & Boechat, N. (2019). Molecules, 24, 4095.

[bb20] Rao, H. S. P., Gunasundari, R. & Muthukumaran, J. (2020). Acta Cryst. E76, 443–445. [DOI] [PMC free article] [PubMed]

[bb21] Ravi, C., Samanta, S., Mohan, D. C., Reddy, N. N. K. & Adimurthy, S. (2017). Synthesis, 49, 2513–2522.

[bb22] Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.

[bb23] Spek, A. L. (2020). Acta Cryst. E76, 1–11. [DOI] [PMC free article] [PubMed]

[bb24] Thomas, S. P., Pavan, M. S. & Guru Row, T. N. (2014). Chem. Commun. 50, 49–51. [DOI] [PubMed]

[bb25] Wu, H.-C., Chu, J.-H., Li, C.-W., Hwang, L.-C. & Wu, M.-J. (2016). Organometallics, 35, 288–300.

[bb26] Ye, Q., Cao, J., Zhou, X., Lv, D., He, Q., Yang, B. & Hu, Y. (2009). Bioorg. Med. Chem. 17, 4763–4772. [DOI] [PubMed]

[bb27] Zhai, M., Liu, S., Gao, M., Wang, L., Sun, J., Du, J., Guan, Q., Bao, K., Zuo, D., Wu, Y. & Zhang, W. (2019). Eur. J. Med. Chem. 168, 426–435. [DOI] [PubMed]

PERMALINK

Crystal structure analysis of ethyl 6-(4-methoxyphenyl)-1-methyl-4-methylsulfanyl-3-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate

H Surya Prakash Rao

Ramalingam Gunasundari

Jayaraman Muthukumaran

Abstract

Chemical context

Structural commentary

Figure 1.